Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8
Chinese Chemical Letters · 2026-10 · 37 (10) · 112111
DOI: 10.1016/j.cclet.2025.112111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-10. Verfasst von Shuyu Wang und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Second Military Medical University, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Second Military Medical University
- National Key Research and Development Program of China
Zitieren
APA
Wang, S., Chai, Y., Shi, J., Dai, P., Yu, R., Shao, H., Ding, W., Xu, L., Liu, R., & Zhuang, C. (2026). Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8. Chinese Chemical Letters, 37(10), 112111. https://doi.org/10.1016/j.cclet.2025.112111
Vancouver
Wang S, Chai Y, Shi J, Dai P, Yu R, Shao H, et al. Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8. Chinese Chemical Letters. 2026;37(10):112111. doi:10.1016/j.cclet.2025.112111
BibTeX
@article{Wang2026,
author = {Wang, Shuyu and Chai, Yue and Shi, Jinxin and Dai, Pengcheng and Yu, Ruizhi and Shao, Hongming and Ding, Wenxin and Xu, Lijuan and Liu, Runhui and Zhuang, Chunlin},
title = {Shikonin ameliorates ulcerative colitis by inhibiting necroptosis via targeting HSPA8},
journal = {Chinese Chemical Letters},
year = {2026},
volume = {37},
number = {10},
pages = {112111},
doi = {10.1016/j.cclet.2025.112111}
}
EUVIMED